Drugmakers Tout New Medicines as Eye Disease Battle Intensifies

By REUTERS
NYT
Switzerland's Roche and Novartis and other drugmakers are touting new treatments for a blindness-causing disease that hits millions of older people, as patent expiries are set to open up one of medicine's most lucrative markets.
Published date: October 29, 2018 at 08:29AM
Reuters
New York Times article